Schedule 13G ownership disclosure
Aura Biosciences Inc
Common Stock, par value $0.00001 per share · CUSIP: 05153U107
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Eventide Asset Management, LLC
Shares: 0.00 · Class: 0%
- Finny Kuruvilla, M.D. Ph. D.
Shares: 0.00 · Class: 0%
- Robin C. John
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-25-003115
- Form type
- SCHEDULE 13G/A
- Filer
- Aura Biosciences, Inc.
- CIK
- CIK 1501796
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership